Macleod, Angus DDalen, IngvildTysnes, Ole-BjørnLarsen, Jan PetterCounsell, Carl E2018-02-012018-02-012018-01-31Macleod, A D, Dalen, I, Tysnes, O-B, Larsen, J P & Counsell, C E 2018, 'Development and validation of prognostic survival models in newly diagnosed Parkinson’s disease', Movement Disorders, vol. 33, no. 1, pp. 108-116. https://doi.org/10.1002/mds.271770885-3185ORCID: /0000-0001-6622-7839/work/164505583ORCID: /0000-0002-6284-4239/work/191926805http://hdl.handle.net/2164/9977Acknowledgments We would like to thank study participants, study personnel, and study funders. Funding agencies: The Parkinsonism Incidence in North-East Scotland (PINE) study was supported by Parkinson's UK (Grants G-0502, G-0914, G-1302), the Scottish Chief Scientist Office (CAF 12/05), the British Medical Association (BMA) Doris Hillier award, RS Macdonald Trust, the Bupa Foundation, National Health Service (NHS) Grampian endowments, NHS R&D, and SPRING. The ParkWest study was supported by the Research Council of Norway (Grant 177966), the Western Norway Regional Health Authority (Grants 911218 and 911949), and the Norwegian Parkinson's Disease Association.9636524engdependencyParkinson's diseaseprognosismortalityRC0321 Neuroscience. Biological psychiatry. NeuropsychiatryParkinson's UKG-0502G-0914G-1302Chief Scientist Office (CSO)CAF 12/05Supplementary DataRC0321Journal article10.1002/mds.27177331